(Q39725023)

14 September 2017

Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome (English)

1 reference

14 September 2017

1 reference

1 reference

Lijing Luo

1

1 reference

14 September 2017

Jianfang Zeng

2

1 reference

14 September 2017

Bing Liang

3

1 reference

14 September 2017

Zhe Zhao

4

1 reference

14 September 2017

Lulu Sun

5

1 reference

14 September 2017

Dongyan Cao

6

1 reference

14 September 2017

Jiaxin Yang

7

1 reference

14 September 2017

Keng Shen

8

1 reference

14 September 2017

20 July 2011

1 reference

Experimental and Molecular Pathology

14 September 2017

1 reference

14 September 2017

91

1 reference

14 September 2017

2

1 reference

14 September 2017

596-602

1 reference

Prospective identification of tumorigenic breast cancer cells

14 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Therapeutic implications of cancer stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Induction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Molecular portraits of intratumoral heterogeneity in human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Somatic activation of KIT in distinct subtypes of melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Phenotypic characterization of human colorectal cancer stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Tumour stem cells and drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Biology of gastrointestinal stromal tumors: KIT mutations and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Identification and expansion of the tumorigenic lung cancer stem cell population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

c-Kit expression in human normal and malignant stem cells prognostic and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Adult bone-marrow stem cells and their potential in medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Normal stem cells and cancer stem cells: the niche matters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Identification of pancreatic cancer stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Involvement of tyrosine kinase signaling in maintaining murine embryonic stem cell functionality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Analysis of c-kit protein expression in small-cell lung carcinoma and its implication for prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Treatment goals in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Correlation of murine embryonic stem cell gene expression profiles with functional measures of pluripotency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

c-KIT expression and correlation with chemotherapy resistance in ovarian carcinoma: an immunocytochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Stem cells, cancer, and cancer stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Identification and expansion of human colon-cancer-initiating cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Identification of cells initiating human melanomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Identification of human brain tumour initiating cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Frequent KIT and epidermal growth factor receptor overexpressions in undifferentiated-type breast carcinomas with 'stem-cell-like' features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Significance of CD90+ cancer stem cells in human liver cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Stem cell factor/c-kit receptor signaling enhances the proliferation and invasion of colorectal cancer cells through the PI3K/Akt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

10.1016/J.YEXMP.2011.06.005

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference